Insilico Medicine Alternatives

Accelerate drug discovery and development with AI-powered tools for target identification, molecule design, and clinical trial outcome prediction.
BenchSci screenshot thumbnail

BenchSci

If you're looking for another Insilico Medicine, BenchSci is worth a look. Its ASCEND platform uses AI to speed up drug discovery and other complex research workflows, taking advantage of a big data set and biology-focused multimodal AI to understand experiments. It's got tools like generative AI-boosted summarization and conversational AI that can help you decide what experiments to run and cut down on failures.

QIAGEN Digital Insights screenshot thumbnail

QIAGEN Digital Insights

Another contender is QIAGEN Digital Insights. This bioinformatics software suite offers expert-curated solutions for genomic and clinical research, helping you turn basic research into patient care. It includes tools for annotating and filtering variants, genomic data analysis and clinical services, and is a good choice for biomarker and target discovery, single-cell genomics and more.

Genesis Therapeutics screenshot thumbnail

Genesis Therapeutics

Genesis Therapeutics has a molecular AI platform designed to speed up small molecule drug discovery with 3D spatial graph modeling and molecular simulation. The GEMS platform predicts properties and generates molecules, with the goal of developing high-potency and selective small molecule drugs for hard-to-drug biological targets. It's a good fit for tackling breakthrough treatments for challenging diseases.

Tempus screenshot thumbnail

Tempus

Last, Tempus has an AI-powered precision medicine platform designed to improve cancer care by providing patient insights, care gap identification and real-world data analysis. It can help pharmaceutical and biotech companies develop drugs and clinical trials and offer personalized therapy options to patients. It's backed by scientific publications and has received FDA Breakthrough Device Designation for its HLA-LOH Companion Diagnostic Test.

More Alternatives to Insilico Medicine

Huma.AI screenshot thumbnail

Huma.AI

Unifies internal and external data sources, providing up-to-date, referenced insights for life sciences professionals to inform decision-making across medical affairs, clinical development, and regulatory affairs.

BIOVIA screenshot thumbnail

BIOVIA

Integrates diverse scientific disciplines and processes end-to-end, enabling organizations to accelerate innovation, improve quality, and streamline research to manufacturing.

JADBio screenshot thumbnail

JADBio

Automates biomarker discovery and interpretation, processing multi-omics data to speed up drug discovery and provide actionable insights for researchers.

Medidata screenshot thumbnail

Medidata

Accelerates clinical research with AI-driven insights, patient-centric interfaces, and data management improvements, speeding new treatments to patients.

Ginkgo Bioworks screenshot thumbnail

Ginkgo Bioworks

Accelerates biological innovation with a data-driven, high-throughput platform, optimizing product development and reducing costs across various industries.

Nextnet screenshot thumbnail

Nextnet

Uncovers hidden connections in biomedicine and life sciences by indexing and linking global information, enabling collaborative hypothesis formation and decision-making.

DrugBank screenshot thumbnail

DrugBank

Access a vast database of over 500,000 drug products, with powerful search and query tools to inform clinical decisions and improve healthcare outcomes.

IQVIA screenshot thumbnail

IQVIA

Intelligent connections between data, expertise, and stakeholders drive results, enabling better decision-making and healthcare progress.

Lavo Life Sciences screenshot thumbnail

Lavo Life Sciences

Accelerates drug development with AI-driven crystal structure prediction, reducing turnaround time and risk while optimizing formulations and discovering new polymorphs.

Enthought screenshot thumbnail

Enthought

Accelerates scientific discovery by 10x and saves scientists up to 80% of their time through AI-driven data tools and streamlined analysis workflows.

Clair screenshot thumbnail

Clair

Streamlines clinical research and decision-making with 90% faster search results, delivering ultra-accurate answers from authoritative sources with references.

NVIDIA AI Platform screenshot thumbnail

NVIDIA AI Platform

Accelerate AI projects with an all-in-one training service, integrating accelerated infrastructure, software, and models to automate workflows and boost accuracy.

Molecular Devices screenshot thumbnail

Molecular Devices

Automates cell culture processes, monitoring, feeding, imaging, and scheduling assays for enhanced reliability and reproducibility in scientific research and discovery.

DataRobot AI Platform screenshot thumbnail

DataRobot AI Platform

Centralize and govern AI workflows, deploy at scale, and maximize business value with enterprise monitoring and control.

RapidAI screenshot thumbnail

RapidAI

Empowers healthcare teams to make informed, timely triage and transfer decisions, leading to faster treatment and better patient care through rapid AI-driven insights.

Clinomics screenshot thumbnail

Clinomics

Identifies cancer genome variants for early detection and treatment through liquid biopsy and personalized genome sequencing, enabling targeted medical care.

C3 AI screenshot thumbnail

C3 AI

Access a broad range of pre-built, enterprise-scale AI applications across industries, accelerating digital transformation and delivering results in weeks.

LifeOmic screenshot thumbnail

LifeOmic

Combines genomic, clinical, imaging, and population data to empower precision health decisions, streamlining workflows and improving patient outcomes.

Clarifai screenshot thumbnail

Clarifai

Rapidly develop, deploy, and operate AI projects at scale with automated workflows, standardized development, and built-in security and access controls.

Glass screenshot thumbnail

Glass

Provides AI-driven clinical decision support, generating differential diagnoses and creating personalized treatment plans based on patient summaries and evidence-based guidelines.